Insider transactions InterCure Ltd.

Stocks

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 08:16:41 15/07/2026 BST			5-day change	1st Jan Change
302.00 ^ILa	+0.73%		-0.92%	-6.67%

06-22	InterCure Ltd. announced that it expects to receive ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors.	CI
06-15	InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition	MT

Date	Insider	Type	Main position	Quantity	Price	Amount	% Market Cap.
03-17	Lennie Grinbaum Michelso	Other	Director	26,149	-	-	0.0478%
03-17	Alexander Rabinovitch	Other	Chief Executive Officer	17,285,455	-	-	31.6113%
03-17	David Salton	Other	Director	19,046	-	-	0.0348%
03-17	Alon Shmuel Granot	Other	Director	15,000	-	-	0.0274%
03-17	Amos Cohen	Other	Chief Financial Officer	539,947	-	-	0.9874%
03-17	Gideon Hirschfeld	Other	Director	19,046	-	-	0.0348%
08/11/22	Amos Cohen	Option	Chief Financial Officer	230,000	-	-	0.5066%
08/11/22	Alexander Rabinovitch	Option	Chief Executive Officer	460,000	-	-	1.0133%
08/11/22	Ram Levy	Option		230,000	-	-	0.5066%
23/03/22	Yael Fegel	Buy		1,823	22.70	41.38K	0.0040%
22/03/22	Yael Fegel	Buy		100,000	22.85	2.28M	0.2216%
21/03/22	Yael Fegel	Buy		48,362	22.50	1.09M	0.1072%
19/03/22	Yael Fegel	Buy		6,000	21.24	127K	0.0133%
19/03/22	Yael Fegel	Buy		3,000	21.08	63.24K	0.0066%
19/03/22	Yael Fegel	Buy		1,224	21.10	25.83K	0.0027%
19/03/22	Yael Fegel	Buy		10,000	21.06	211K	0.0222%
12/09/21	Amos Cohen	Option	Chief Financial Officer	95,291	-	-	0.2233%
12/09/21	Ram Levy	Option		41,408	-	-	0.0970%
09/09/21	Alexander Rabinovitch	Option	Chief Executive Officer	2,150,919	-	-	5.0407%
09/09/21	Alexander Rabinovitch	Option	Chief Executive Officer	2,150,919	0.52	1.12M	5.0407%